IOBCF
Price
$11.15
Change
-$0.65 (-5.51%)
Updated
May 1 closing price
Capitalization
472.05M
IVRO
Price
$0.08
Change
-$0.01 (-11.11%)
Updated
May 1 closing price
Capitalization
911.82K
Ad is loading...

IOBCF vs IVRO

Header iconIOBCF vs IVRO Comparison
Open Charts IOBCF vs IVROBanner chart's image
Ion Beam Applications S.A
Price$11.15
Change-$0.65 (-5.51%)
Volume$150
Capitalization472.05M
InVitro International
Price$0.08
Change-$0.01 (-11.11%)
Volume$102.04K
Capitalization911.82K
IOBCF vs IVRO Comparison Chart
Loading...
View a ticker or compare two or three
VS
IOBCF vs. IVRO commentary
May 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOBCF is a Hold and IVRO is a Hold.

Ad is loading...
COMPARISON
Comparison
May 02, 2025
Stock price -- (IOBCF: $11.15 vs. IVRO: $0.08)
Brand notoriety: IOBCF and IVRO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IOBCF: 33% vs. IVRO: 969%
Market capitalization -- IOBCF: $472.05M vs. IVRO: $911.82K
IOBCF [@Medical Specialties] is valued at $472.05M. IVRO’s [@Medical Specialties] market capitalization is $911.82K. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOBCF’s FA Score shows that 1 FA rating(s) are green whileIVRO’s FA Score has 1 green FA rating(s).

  • IOBCF’s FA Score: 1 green, 4 red.
  • IVRO’s FA Score: 1 green, 4 red.
According to our system of comparison, IVRO is a better buy in the long-term than IOBCF.

Price Growth

IOBCF (@Medical Specialties) experienced а +0.35% price change this week, while IVRO (@Medical Specialties) price change was -23.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.46%. For the same industry, the average monthly price growth was +1.12%, and the average quarterly price growth was -0.05%.

Industries' Descriptions

@Medical Specialties (+4.46% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
IOBCF($472M) has a higher market cap than IVRO($912K). IVRO YTD gains are higher at: -15.385 vs. IOBCF (-19.495).
IOBCFIVROIOBCF / IVRO
Capitalization472M912K51,754%
EBITDA22MN/A-
Gain YTD-19.495-15.385127%
P/E Ratio68.03N/A-
Revenue336MN/A-
Total Cash195MN/A-
Total Debt64.7MN/A-
FUNDAMENTALS RATINGS
IOBCF vs IVRO: Fundamental Ratings
IOBCF
IVRO
OUTLOOK RATING
1..100
2287
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
7796
SMR RATING
1..100
789
PRICE GROWTH RATING
1..100
7644
P/E GROWTH RATING
1..100
7395
SEASONALITY SCORE
1..100
5047

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOBCF's Valuation (10) in the null industry is somewhat better than the same rating for IVRO (73). This means that IOBCF’s stock grew somewhat faster than IVRO’s over the last 12 months.

IOBCF's Profit vs Risk Rating (77) in the null industry is in the same range as IVRO (96). This means that IOBCF’s stock grew similarly to IVRO’s over the last 12 months.

IVRO's SMR Rating (9) in the null industry is significantly better than the same rating for IOBCF (78). This means that IVRO’s stock grew significantly faster than IOBCF’s over the last 12 months.

IVRO's Price Growth Rating (44) in the null industry is in the same range as IOBCF (76). This means that IVRO’s stock grew similarly to IOBCF’s over the last 12 months.

IOBCF's P/E Growth Rating (73) in the null industry is in the same range as IVRO (95). This means that IOBCF’s stock grew similarly to IVRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WASH27.960.36
+1.30%
Washington Trust Bancorp
LYFT12.460.06
+0.48%
Lyft
TLRY0.49N/A
+0.08%
Tilray Brands
ASML666.72-1.36
-0.20%
ASML Holding NV
CRBU0.80-0.05
-5.77%
Caribou Biosciences

IOBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBCF has been loosely correlated with ANSLY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBCF jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBCF
1D Price
Change %
IOBCF100%
-5.51%
ANSLY - IOBCF
43%
Loosely correlated
N/A
BRSYF - IOBCF
39%
Loosely correlated
N/A
PXMBF - IOBCF
30%
Poorly correlated
N/A
FSPKF - IOBCF
21%
Poorly correlated
N/A
VERO - IOBCF
20%
Poorly correlated
-1.65%
More

IVRO and

Correlation & Price change

A.I.dvisor tells us that IVRO and ECIA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVRO and ECIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVRO
1D Price
Change %
IVRO100%
-14.44%
ECIA - IVRO
20%
Poorly correlated
N/A
NMTC - IVRO
20%
Poorly correlated
-0.90%
IOBCF - IVRO
13%
Poorly correlated
-5.51%
KLYG - IVRO
9%
Poorly correlated
N/A
GCTK - IVRO
8%
Poorly correlated
+1.21%
More